Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
31.79
+0.20 (0.63%)
At close: Jan 22, 2026, 4:00 PM EST
32.42
+0.63 (1.98%)
After-hours: Jan 22, 2026, 5:05 PM EST
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $1.72 billion as of January 22, 2026. Its market cap has increased by 88.76% in one year.
Market Cap
1.72B
Enterprise Value
1.35B
1-Year Change
88.76%
Ranking
Category
Stock Price
$31.79
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has increased from $393.35M to $1.72B, an increase of 336.73%. That is a compound annual growth rate of 215.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 1.72B | 17.09% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 1.71B |
| Immunocore Holdings | 1.68B |
| Celldex Therapeutics | 1.68B |
| MannKind | 1.66B |
| Biohaven | 1.66B |
| Oruka Therapeutics | 1.61B |
| Kodiak Sciences | 1.61B |
| Tyra Biosciences | 1.60B |